ArticleWellcome open research2018

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).

May Ee Png et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.